Clinical Trial Update: Study of ST-1898 in Advanced Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ST-1898 in advanced renal cell carcinoma, currently in Phase 1/Phase 2 and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• ST-1898

Snippet

Sponsor: Beijing Scitech-Mq Pharmaceuticals Limited | Conditions: Advanced Renal Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING